Osteoblast-derived factors induce an expression signature that identifies prostate cancer metastasis and hormonal progression.
Identification of gene expression signatures associated with metastases provides a tool to discern mechanisms and potential therapeutic targets and may lead toward a molecular classification system in pathology. Prostate cancer (CaP) frequently metastasizes to the bone to form osteoblastic lesions. Correlative clinical data and in vitro evidence have led to the hypothesis that osteoblast-derived factors promote hormonal progression of CaP cells. Here, the gene expression signature of CaP exposed to osteoblast-derived factors was identified. This signature included known androgen-regulated genes, oncogenes, tumor suppressors, and genes whose products are involved in apoptosis and cell cycle. A comparative functional genomic approach involved the application of this responsive gene expression signature to clinical samples of human CaP, melanomas, and oral cancers. Cluster analysis revealed that this gene expression signature had specificity for CaP and could resolve clinical specimens according to stage (benign, localized, and metastatic) and androgen sensitivity with an accuracy of 100% and 80%, respectively. Together, these results suggest that factors derived from osteoblasts induce a more advanced phenotype of CaP and promotes hormonal progression.
Genome Sciences Centre, British Columbia Cancer Agency, Canada.
Gang
G
Wang
Simon
S
Haile
Barbara
B
Comuzzi
Amy H
AH
Tien
Jun
J
Wang
Theresa M K
TM
Yong
Anca E
AE
Jelescu-Bodos
Natalie
N
Blaszczyk
Robert L
RL
Vessella
Bassam A
BA
Masri
Marianne D
MD
Sadar
D000818:Animals; D001859:Bone Neoplasms / Q000235:genetics* / Q000556:secondary; D020869:Gene Expression Profiling; D006801:Humans; D008297:Male; D051379:Mice; D008819:Mice, Nude; D009376:Neoplasms, Hormone-Dependent / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D010006:Osteoblasts / Q000378:metabolism* / Q000473:pathology; D011471:Prostatic Neoplasms / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D014020:Tissue Extracts / Q000494:pharmacology; D014183:Transplantation, Heterologous
D014020:Tissue Extracts